Keiji Nishida

Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service.

Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir.

F-Prime UK Ltd. was founded in 2007 and provides strategy development, market research, investment advisory, and administration support services. The private company is based in London, UK.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA.

Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor.

Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation.

Proof Diagnostics, Inc. is a company that specializes in providing affordable and accessible COVID-19 molecular testing using CRISPR technology. The company is based in Cambridge, MA. Led by world-renowned molecular biologist Dr. Feng Zhang, the company aims to help communities take control of their health. Proof Diagnostics was founded in 2020 by Feng Zhang, Sid Shenai, Jonathan Gootenberg, Omar Abudayyeh. Sid Shenai has been the CEO since 2020.

Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya.

Paradigm Health, Inc. develops a platform for clinical research. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Milind Kamkolkar. Kent Thoelke has been the CEO of the company since 2023.

Biomaster, Inc. engages in the operation and management of a hospitals. It specializes in cell-assisted lipotransfer tissue augmentation procedures. It offers various medical services using cell-assisted lipotransfer tissue augmentation procedures, such as breast augmentation, breast reconstruction and restoration, wrinkle removal, and buttock lift. It also involves in the integration of regenerative medicine and plastic surgery, as well as offers various services, including cell source development, tissue/cell banking, development and sale of devices, development of cell preservation, cultivation, and transplantation technologies. The company was founded on December 25, 2002 and is headquartered in Yokohama, Japan.

Eight Roads Ventures Japan is a Private Equity/Venture Capital firm, a subsidiary of FIL Ltd. founded in 2008. Eight Roads Ventures Japan is headquartered in Tokyo.

Mikatus Inc. provides accounting system solutions. It develops and sale of cloud-based accounting systems and tax application software for professional accounting firms. It also provides accounting equipment sales, systems maintenance, and portal site development. The company was founded by Toshinao Morizaki in June 2009 and is headquartered in Tokyo, Japan.

Azit, Inc. develops software applications for car sharing transportation. The Japanese company was founded in 2013 by Shinichiro Sudo and Hiromasa Yoshikane. Hiromasa Yoshikane has been the CEO since 2013.

SDP Japan KK is a company that was founded in 2014 and is based in Tokyo, Japan. The Japanese company produces supercutors to concentrate on medical care and has a joint purchase business of medical materials. SDP is a platformer that contributes to the medical industry by producing super doctors in a unique business model that has never been seen before. The company aims to create a medical environment where doctors can be engaged with pride and provide surgery to patients early to support the healthy and happy life of patients through medical care. The eternal director, who has launched about 30 companies in a wide variety of industries, is aiming in the medical industry.

Sensyn Robotics, Inc. provides robotics services for visual communication through drones. The drones can be used for disaster measures and maintenance and inspection for social infrastructure and large scale facilities or plants. The company was founded in October 2015 and is headquartered in Tokyo, Japan.

CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA.

Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston.

Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA.

FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA.

Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut.

NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.

Iora Health, Inc. engages in the provision of healthcare services. It operates a primary care practice for college employees and their adult dependents; a clinic that serves hotel and restaurant workers; a family practice for individuals who receive health insurance; and a primary care practice to provide services to carpenters and their family members. The company was founded by Rushika Fernandopulle and Christopher J. McKown in 2010 and is headquartered in Cambridge, MA.

Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom.